In this report, the production of Human Growth Hormone increased from 170.67 Million IU in 2012 to 209 Million IU in 2016 with an average growth rate of 5.20%.
Growth hormone (GH), also known as somatotropin (or as human growth hormone in its human form), is a peptide hormone that stimulates growth, cell reproduction, and cell regeneration in humans and other animals. It is thus important in human development. It is a type of mitogen which is specific only to certain kinds of cells. Growth hormone is a 191-amino acid, single-chain polypeptide that is synthesized, stored, and secreted by somatotropic cells within the lateral wings of the anterior pituitary gland.
The downstream industries of Human Growth Hormone products are kids and adults. In the recent years, with the recovery of global economic, the development of emerging countries and the rising health concern, the consumption increase of Human Growth Hormone will be obvious.
For industry structure analysis, the Human Growth Hormone industry is very concentrated. These manufacturers ranging from large multinational corporations to small privately owned companies compete in this industry. The top five producers account for more than 80% of the revenue market. Regionally, North America is the biggest production value area of valves, also the leader in the whole Human Growth Hormone industry.
North America occupied about 42.7% of the production market in 2016. It was followed by Europe and China, which respectively have around 27% and 17% of the global total industry. Other countries have a small amount of production. Geographically, North America was the largest consumption market in the world, which took about 44.6% of the global consumption volume in 2015.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (M USD), market share and growth rate of Human Growth Hormone in these regions, from 2014 to 2026 (forecast), covering
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
South America (Brazil, Argentina, Columbia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Global Human Growth Hormone market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Novo Nordisk
Pfizer
Eli Lilly
Merck Serono
F.Hoffmann-LaRoche
Ferring Pharmaceuticals
GeneScience Pharmaceuticals
Ipsen
LG Life Sciences
Sandoz International
Anhui Anke Biotechnology
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Powder
Solvent
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Human Growth Hormone for each application, including
Growth Hormone Deficiency (GHD)
Turner Syndrome
Chronic Renal Insufficiency
Prader Willi Syndrome
Small for Gestational Age
SHOX Deficiency
Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
Global Human Growth Hormone Market by Manufacturers, Regions, Type and Application, Forecast to 2026
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Human Growth Hormone Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Assessment by Type
2.1 Powder Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.2 Solvent Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
3 Asia Pacific Human Growth Hormone Market Assessment by Type
3.1 Asia Pacific Market Performance (Sales, Revenue)
3.2 Key Players in Asia Pacific
4 North America Human Growth Hormone Market Assessment by Type
4.1 North America Market Performance (Sales, Revenue)
4.2 Key Players in North America
5 Europe Human Growth Hormone Market Assessment by Type
4.1 Europe Market Performance (Sales, Revenue)
4.2 Key Players in Europe
6 South America Human Growth Hormone Market Assessment by Type
4.1 South America Market Performance (Sales, Revenue)
4.2 Key Players in South America
7 Middle Easr and Africa Human Growth Hormone Market Assessment by Type
4.1 Middle Easr and Africa Market Performance (Sales, Revenue)
4.2 Key Players in Middle Easr and Africa
8 World Human Growth Hormone Market Assessment by Type
8.1 Asia Pacific Human Growth Hormone Market Assessment by Application (Consumption and Market Share)
8.2 North America Human Growth Hormone Market Assessment by Application (Consumption and Market Share)
8.3 Europe Human Growth Hormone Market Assessment by Application (Consumption and Market Share)
8.4 South America Human Growth Hormone Market Assessment by Application (Consumption and Market Share)
8.5 Middle East and Africa Human Growth Hormone Market Assessment by Application (Consumption and Market Share)
9 Company Profiles/Analysis
9.1 Novo Nordisk
9.1.1 Novo Nordisk Profiles
9.1.2 Novo Nordisk Product Portfolio
9.1.3 Novo Nordisk Human Growth Hormone Business Performance
9.1.4 Novo Nordisk Human Growth Hormone Business Development and Market Status
9.2 Pfizer
9.2.1 Pfizer Profiles
9.2.2 Pfizer Product Portfolio
9.2.3 Pfizer Human Growth Hormone Business Performance
9.2.4 Pfizer Human Growth Hormone Business Development and Market Status
9.3 Eli Lilly
9.3.1 Eli Lilly Profiles
9.3.2 Eli Lilly Product Portfolio
9.3.3 Eli Lilly Human Growth Hormone Business Performance
9.3.4 Eli Lilly Human Growth Hormone Business Development and Market Status
9.4 Merck Serono
9.4.1 Merck Serono Profiles
9.4.2 Merck Serono Product Portfolio
9.4.3 Merck Serono Human Growth Hormone Business Performance
9.4.4 Merck Serono Human Growth Hormone Business Development and Market Status
9.5 F.Hoffmann-LaRoche
9.5.1 F.Hoffmann-LaRoche Profiles
9.5.2 F.Hoffmann-LaRoche Product Portfolio
9.5.3 F.Hoffmann-LaRoche Human Growth Hormone Business Performance
9.5.4 F.Hoffmann-LaRoche Human Growth Hormone Business Development and Market Status
9.6 Ferring Pharmaceuticals
9.6.1 Ferring Pharmaceuticals Profiles
9.6.2 Ferring Pharmaceuticals Product Portfolio
9.6.3 Ferring Pharmaceuticals Human Growth Hormone Business Performance
9.6.4 Ferring Pharmaceuticals Human Growth Hormone Business Development and Market Status
9.7 GeneScience Pharmaceuticals
9.7.1 GeneScience Pharmaceuticals Profiles
9.7.2 GeneScience Pharmaceuticals Product Portfolio
9.7.3 GeneScience Pharmaceuticals Human Growth Hormone Business Performance
9.7.4 GeneScience Pharmaceuticals Human Growth Hormone Business Development and Market Status
9.8 Ipsen
9.8.1 Ipsen Profiles
9.8.2 Ipsen Product Portfolio
9.8.3 Ipsen Human Growth Hormone Business Performance
9.8.4 Ipsen Human Growth Hormone Business Development and Market Status
9.9 LG Life Sciences
9.9.1 LG Life Sciences Profiles
9.9.2 LG Life Sciences Product Portfolio
9.9.3 LG Life Sciences Human Growth Hormone Business Performance
9.9.4 LG Life Sciences Human Growth Hormone Business Development and Market Status
9.10 Sandoz International
9.10.1 Sandoz International Profiles
9.10.2 Sandoz International Product Portfolio
9.10.3 Sandoz International Human Growth Hormone Business Performance
9.10.4 Sandoz International Human Growth Hormone Business Development and Market Status
9.11 Anhui Anke Biotechnology
10 World Human Growth Hormone Market Assessment by Players
10.1 Global Human Growth Hormone Sales (K Units) and Market Share by Players 2014-2020
10.2 Global Human Growth Hormone Revenue (M USD) and Market Share by Players 2014-2020
10.3 Global Human Growth Hormone Price (USD/Unit) of Players 2014-2020
10.4 Global Human Growth Hormone Gross Margin of Players 2014-2020
10.5 Market Concentration
11 Regional Market Performance by Segment of Players
11.1 North America
11.1.1 North America Human Growth Hormone Sales Assessment of Players 2014-2020
11.1.2 North America Human Growth Hormone Revenue Assessment of Players 2014-2020
11.1.3 North America Human Growth Hormone Price Assessment of Players 2014-2020
11.1.4 North America Human Growth Hormone Gross Margin Assessment of Players 2014-2020
11.1.5 Market Concentration
11.2 Europe
11.2.1 Europe Human Growth Hormone Sales Assessment of Players 2014-2020
11.2.2 Europe Human Growth Hormone Revenue Assessment of Players of Manufacturers 2014-2020
11.2.3 Europe Human Growth Hormone Price Assessment of Players 2014-2020
11.2.4 Europe Human Growth Hormone Gross Margin Assessment of Players 2014-2020
11.2.5 Market Concentration
11.3 Asia-Pacific Market Performance for Manufacturers
11.3.1 Asia-Pacific Human Growth Hormone Sales Assessment of Players 2014-2020
11.3.2 Asia-Pacific Human Growth Hormone Revenue Assessment of Players 2014-2020
11.3.3 Asia-Pacific Human Growth Hormone Price Assessment of Players 2014-2020
11.3.4 Asia-Pacific Human Growth Hormone Gross Margin Assessment of Players 2014-2020
11.3.5 Market Concentration
11.4 South America Market Performance for Players
11.4.1 South America Human Growth Hormone Sales Assessment of Players 2014-2020
11.4.2 South America Human Growth Hormone Revenue Assessment of Players 2014-2020
11.4.3 South America Human Growth Hormone Price Assessment of Players 2014-2020
11.4.4 South America Human Growth Hormone Gross Margin Assessment of Players 2014-2020
11.4.5 Market Concentration
11.5 Middle East and Africa Market Performance for Players
11.5.1 Middle East and Africa Human Growth Hormone Sales Assessment of Players 2014-2020
11.5.2 Middle East and Africa Human Growth Hormone Revenue Assessment of Players 2014-2020
11.5.3 Middle East and Africa Human Growth Hormone Price Assessment of Players 2014-2020
11.5.4 Middle East and Africa Human Growth Hormone Gross Margin Assessment of Players 2014-2020
11.5.5 Market Concentration
12 Regional Market Performance by Segment of Countries
12.1 Asia Pacific
12.1.1 Asia Pacific Human Growth Hormone Sales by Countries/Regions 2014-2020
12.1.2 Asia Pacific Human Growth Hormone Revenue by Countries/Regions 2014-2020
12.1.3 Asia Pacific Human Growth Hormone Average Price by Countries/Regions 2014-2020
12.2 North America
12.2.1 North America Human Growth Hormone Sales by Countries/Regions 2014-2020
12.2.2 North America Human Growth Hormone Revenue by Countries/Regions 2014-2020
12.2.3 North America Human Growth Hormone Average Price by Countries/Regions 2014-2020
12.3 Europe
12.3.1 Europe Human Growth Hormone Sales by Countries/Regions 2014-2020
12.3.2 Europe Human Growth Hormone Revenue by Countries/Regions 2014-2020
12.3.3 Europe Human Growth Hormone Average Price by Countries/Regions 2014-2020
12.4 South America
12.4.1 South America Human Growth Hormone Sales by Countries/Regions 2014-2020
12.4.2 South America Human Growth Hormone Revenue by Countries/Regions 2014-2020
12.4.3 South America Human Growth Hormone Average Price by Countries/Regions 2014-2020
12.5 Middle East and Africa
12.5.1 Middle East and Africa Human Growth Hormone Sales by Countries/Regions 2014-2020
12.5.2 Middle East and Africa Human Growth Hormone Revenue by Countries/Regions 2014-2020
12.5.3 Middle East and Africa Human Growth Hormone Average Price by Countries/Regions 2014-2020
13 Technology and Opportunity
13.1 Technology
13.2 Market Opportunity
14 World Human Growth Hormone Sales & Revenue Forecast 2021-2026
14.1 World Human Growth Hormone Sales and Revenue Forecast by Regions 2021-2026
14.1.1 World Human Growth HormoneSales and Market Share by Regions
14.1.2 World Human Growth HormoneRevenue and Market Share by Regions
15 Asia Human Growth Hormone Market Forecast 2021-2026
15.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
15.1.1 Powder
15.1.2 Solvent
15.2 Consumption Forecast by Application, 2021-2026
16 North America Human Growth Hormone Market Forecast 2021-2026
16.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
16.1.1 Powder
16.1.2 Solvent
16.2 Consumption Forecast by Application, 2021-2026
17 Europe Human Growth Hormone Market Forecast 2021-2026
17.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
17.1.1 Powder
17.1.2 Solvent
17.2 Consumption Forecast by Application, 2021-2026
18 South America Human Growth Hormone Market Forecast 2021-2026
18.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
18.1.1 Powder
18.1.2 Solvent
18.2 Consumption Forecast by Application, 2021-2026
19 Middle East and Africa Human Growth Hormone Market Forecast 2021-2026
19.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
19.1.1 Powder
19.1.2 Solvent
19.2 Consumption Forecast by Application, 2021-2026
20 Price (USD/Unit) and Gross Profit Forecast
20.1 Global Human Growth Hormone Price (USD/Unit) Trend 2021-2026
20.2 Global Human Growth Hormone Gross Profit Trend 2021-2026
21 Conclusion
| Price : US$ 3500 | Date : Apr 2024 |
| Category : Healthcare and Pharmaceuticals | Pages : 129 |
| Price : US$ 3500 | Date : Apr 2024 |
| Category : Healthcare and Pharmaceuticals | Pages : 154 |
| Price : US$ 3500 | Date : Apr 2024 |
| Category : Manufacturing and Construction | Pages : 125 |
| Price : US$ 3500 | Date : Apr 2024 |
| Category : Consumer Goods and Retail | Pages : 123 |
| Price : US$ 3500 | Date : Apr 2024 |
| Category : Consumer Goods and Retail | Pages : 150 |
We will be happy to help you find what you need. Please call us or write to us:
Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).
This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection
Request Sample 
Request Discount 
Inquire Before Buy
